City of McAllen includes e-cigarettes in smoking ordinance

Translate to Spanish or other 102 languages!

Texas Border Business

- Advertisement -

McAllen– Electronic cigarettes are now included in the current smoking ordinance in the City of McAllen.

During the regular city commission meeting, changes were approved to the smoking regulations.  As of November 11, 2015, the smoking ordinance will now include the definition of “Lighted” or “Lighting”, and amend the definition of “Smoke” or “Smoking” by including e-cigarettes.

Locations where smoking is prohibited will now have prohibition for e-cigarettes.

- Advertisement -

Prior to the November 9 amendments, smoking was prohibited in certain enclosed public places and outdoor facilities as prescribed under McAllen Code of Ordinances Chapter 54, Article V, Smoking Regulations.  However, the original text did not account for the smoking of e-cigarettes and vaping devices. 

McAllen Code Enforcement encourages business owners to notify their clients and post proper signage. During the current educational phase, anyone in violation of the ordinance will be notified of the change and be given a warning. Effective Jan. 1, individuals caught vaping will be issued a citation.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -